Barclays Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $115
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Christopher Pasquale maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $100 to $115.
Barclays analyst Christopher Pasquale maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $100 to $115.